Home > Boards > US OTC > Medical - Healthcare > Item 9 Labs Corp. (INLB)

Item 9 Labs Corp. Launches New Vape Pen

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Stockshound Member Profile
 
Followed By 4
Posts 446
Boards Moderated 0
Alias Born 08/06/19
160x600 placeholder
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 3/6/2020 5:13:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2020 5:26:33 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/19/2020 5:24:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2020 5:13:09 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 2/18/2020 6:02:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2020 4:13:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2020 1:53:04 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 12/30/2019 5:16:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 5:21:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 1:30:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/10/2019 5:09:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/10/2019 5:07:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:20:51 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/29/2019 1:09:35 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/29/2019 9:10:01 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 5:06:11 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:57:27 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:34:28 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:33:07 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:32:20 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:31:33 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/28/2019 4:29:49 PM
Amended Securities Registration (section 12(g)) (10-12g/a) Edgar (US Regulatory) - 8/22/2019 2:50:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2019 6:06:17 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/15/2019 6:12:14 AM
Stockshound   Wednesday, 08/14/19 10:58:55 AM
Re: None
Post # of 155 
Item 9 Labs Corp. Launches New Vape Pen and Cartridge Line Dubbed “Cocktails”

PHOENIX, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced the launch of its new product suite, “Cocktails,” a unique first to market disposable vape pen with cartridge and battery inspired by popular culture’s classic aperitifs.

The Item 9 Labs mixology team developed the craft-cannabis line utilizing organic fruit, botanically-derived terpenes, and 100 percent solvent-free distillate. The long-lasting disposable Cocktails vape pen is supplemented by a charging port for those patients who medicate less frequently. Cocktails comes with 300 mg. of premium distillate in four signature flavors including Blackberry Mojito, Piña Colada, Old Fashioned, and Strawberry Daiquiri.

With eye popping premium packaging and a minimalist sleek design, the Cocktails vape pen features a robust 280mAH breath-activated battery that lasts for approximately 300 inhales between recharges, offering cannabis patients a discreet, portable, and easy way to medicate.

The Company hosted an official brand kick-off event in Phoenix on July 26th. Nearly three hundred cannabis industry professionals attended the private event, where budtenders, buyers, and management from ten area dispensaries enjoyed a custom curated menu and themed cocktails celebrating the new product.

“The Cocktails brand embodies the company mantra ‘in good times.’ It’s a fresh approach to the growing wellness trend of alcohol-free bars coupled with the rise in vape product consumption,” stated Vice President of Marketing, Kyle Jennings.

According to Arcview Market Research, U.S. concentrate product sales are estimated to reach $8.4 billion by 2022, with vaping as the primary modality.

Headquartered in Phoenix, Item 9 Labs has received multiple accolades for its medical-grade flower and concentrates. Most recently, the Company’s Candyland and Tres Leches cannabis flower strains were named 1st Place Sativa and 2nd Place Hybrid respectively at Arizona’s 2019 Errl Cup Awards.

Item 9 Labs is bringing dynamic product suites and progressive new delivery platforms to the industry. Cocktails is available at select Arizona dispensaries, for more information visit Item9LabsCorp.com.

About Item 9 Labs Corp.:

Item 9 Labs Corp. (INLB) creates comfortable cannabis health solutions for the modern consumer. The Company is bringing best of industry practices to markets from coast to coast through cultivation and production, distinctive retail environments, licensing services, and diverse product suites catering to different medical cannabis demographics. Item 9 Labs Corp. is headquartered in Phoenix, Arizona, with medical cannabis operations in multiple U.S. markets.

Item 9 Labs Corp.’s asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. These assets provide services specific to different stakeholder groups. Dispensary Permits is the Company’s consulting firm specializing in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with an extensive digital library of licensing and business planning resources. Strive Life is a turnkey dispensary model for the retail sector, elevating the patient experience with consistent and superior service, high-end design, and precision-tested products. It is currently being implemented in Arizona and North Dakota.

In addition, Item 9 Labs Corp. is advancing the industry with its dynamic product suites. The Company has created complementary brands Item 9 Labs and Strive Wellness to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, as well as a pioneering intra-nasal device. The Company has received multiple accolades for its medical-grade flower and concentrates.

Item 9 Labs Corp. intends to manage cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of 2019. Current facilities include distribution and processing operation Strive Wellness of Nevada and dispensary Strive Life North Dakota.

For more information, visit Item 9 Labs Corp. at www.Item9labscorp.com.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist